HCA Healthcare Inc (NYSE:HCA)
$ 382.19 +5.69 (+1.51%) Market Cap: 84.78 Bil Enterprise Value: 138.65 Bil PE Ratio: 13.14 PB Ratio: 0 GF Score: 93/100

Q2 2026 HCA Healthcare Inc Earnings Call Transcript

Jul 24, 2026 / 02:00PM GMT
Release Date Price: $382.19 (+1.51%)

Key Points

Positve
  • HCA Healthcare Inc (HCA) reported solid diluted earnings per share growth of 11% in the quarter and year-to-date.
  • The company experienced strong demand with volume growth, particularly in emergency room visits, cardiac procedures, and rehab volumes.
  • HCA Healthcare Inc (HCA) has approved more than $7 billion in capital expenditures to expand capacity and facilities over the next three years.
  • The company continues to see improvement in cost metrics through its financial resiliency program, focusing on digital transformation and operational efficiency.
  • HCA Healthcare Inc (HCA) maintains a strong balance sheet, with debt to adjusted EBITDA leverage in the lower half of its target range, allowing for continued investment and shareholder returns.
Negative
  • HCA Healthcare Inc (HCA) faced an unfavorable payer mix shift, with a significant decline in patients covered by health insurance exchanges, leading to increased uninsured volumes.
  • The expiration of enhanced premium tax credits resulted in a greater-than-expected number of uninsured patients, impacting financial performance.
  • Inpatient and outpatient surgeries declined, attributed to reduced demand in elective procedures and the payer mix shift.
  • The company revised its guidance for 2026, reflecting a more moderate growth rate in adjusted EBITDA due to the challenges faced in the first half of the year.
  • Cash flow from operations declined by 45% compared to the prior year quarter, primarily due to timing differences in cash flows related to Medicaid supplemental payment programs.
Operator

Ladies and gentlemen, welcome to the HCA Healthcare second-quarter 2026 earnings conference call. Today's call is being recorded.

At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.

Frank Morgan
HCA Healthcare Inc - Vice President - Head of Investor Relations

Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and CFO, Mike Marks. Sam and Mike will provide some prepared remarks, and then we'll take questions.

Before I turn the call over to Sam, let me remind everyone that should today's call contain any forward-looking statements, they are based on management's current expectations. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings.

On this morning's call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot